First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Published 2014 View Full Article

Authors

Keywords

Neurofibrillary Degeneration, Neurofibrillary Pathology, Keyhole Limpet Haemocyanin, Active Vaccine, Safety Pharmacology Study

Journal

Alzheimers Research & Therapy

Volume 6, Issue 4, Pages 44

Publisher

Springer Nature

Online

2014-08-01

DOI

10.1186/alzrt278

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started